When we analyzed GLUT12 mRNA expression levels in breast cancer patient cohorts using the KMplotter online tool, we observed a decrease in overall survival and recurrence-free survival in patients with high GLUT12 expression (Fig. 3). The gene discussed is SLC2A12; the disease is breast carcinoma.